PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

NCT03594760 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST: 18F-DCFPyL IV injection

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)